Back to results
US 2023/0417761 A1Published application
Detection and quantification of natalizumab
AssigneeAbreos Biosciences, Inc.
InventorsBradley T. MESSMER, Dina UZRI, Jessie-Farah FECTEAU
Life of this patent
Estimating the term…
Abstract
Methods and assays for detecting natalizumab in a sample, natalizumab-peptide complexes in a sample, and point-of-care devices for detecting natalizumab in a sample are described herein.
Claims20
A test device comprising:
- (a) a sample pad for receiving a sample from a subject, wherein the sample comprises an antibody or a fragment of the antibody;
- (b) a conjugate pad;
- and
- (c) a test membrane comprising a first test line comprising a peptide consisting of any one of SEQ ID NOs:
- 1, 2, 4, 13, 16, and 18-23.
2 more elements
Dependencies are inferred from the claim text.